Molecular profiling of blastic transformation in chronic myeloid leukemia

被引：0
|
作者：
Ochi, Yotaro [1 ,2 ]
Yoshida, Kenichi [3 ]
Shiozawa, Yusuke [3 ]
Nannya, Yasuhito [3 ]
Shiraishi, Yuichi [4 ]
Tanaka, Hiroko [4 ]
Chiba, Kenichi [4 ]
Miyano, Satoru [4 ]
Takaori-Kondo, Akifumi [2 ]
Ogawa, Seishi [3 ]
机构：
[1] Kyoto Univ, Pathol & Tumor Biol, Kyoto, Japan
[2] Kyoto Univ, Hematol & Oncol, Kyoto, Japan
[3] Kyoto Univ, Dept Path & Tumor Biol, Kyoto, Japan
[4] Univ Tokyo, Lab DNA Informat Anal, Tokyo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-2087
引用
收藏
页码：743 / 743
页数：1
相关论文
共 50 条
  • [41] Blastic Transformation in Mexican Population With Chronic Myelomonocytic Leukemia
    Rivera Duarte, Alfonso
    Armengol Alonso, Alejandra
    Sandoval Cartagena, Elena
    Tuna Aguilar, Elena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (08): : 532 - 538
  • [42] CURRENT STATUS OF BLASTIC TRANSFORMATION IN CHRONIC MYELOGENOUS LEUKEMIA
    BARTON, JC
    CONRAD, ME
    AMERICAN JOURNAL OF HEMATOLOGY, 1978, 4 (03) : 281 - 291
  • [43] Fas (CD95) expression as a prognostic marker in acute leukemia and blastic transformation phase in chronic myeloid leukemia
    Nosair, Nahla A.
    Abd El Bar, Enaam S.
    Taha, Atef M.
    Gawaly, Amr M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2014, 39 (01): : 25 - 31
  • [44] EXTRAMEDULLARY MANIFESTATIONS OF BLASTIC TRANSFORMATION OF CHRONIC GRANULOCYTIC LEUKEMIA - MENINGEAL LEUKEMIA
    SCHWARTZ, JH
    CANELLOS, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 42 - 42
  • [45] Chromosomal Aberrations in Chronic Myeloid Leukemia: Response to conventional tyrosine kinase inhibitors and risk of blastic transformation
    Maqsood, S.
    Ali, F.
    Siddiqui, N.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 158 - 158
  • [46] BASOPHIL PRODUCTION IN MYELOPROLIFERATIVE DISORDERS - INCREASES DURING ACUTE BLASTIC TRANSFORMATION OF CHRONIC MYELOID-LEUKEMIA
    DENBURG, JA
    WILSON, WEC
    BIENENSTOCK, J
    BLOOD, 1982, 60 (01) : 113 - 120
  • [47] Chromosomal Aberrations in Chronic Myeloid Leukemia: Response to conventional tyrosine kinase inhibitors and risk of blastic transformation
    Maqsood, S.
    Siddiqui, N.
    Ali, F.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E46 - E46
  • [48] A complex karyotype in promyelocytic-like blastic transformation of Ph-positive chronic myeloid leukemia
    Panani, AD
    Stamouli, M
    Harhalakis, N
    Nikiforakis, M
    Roussos, C
    CANCER GENETICS AND CYTOGENETICS, 2005, 158 (01) : 92 - 94
  • [49] Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
    Gong, Zimu
    Medeiros, L. Jeffrey
    Cortes, Jorge E.
    Chen, Zi
    Zheng, Lan
    Li, Yan
    Bai, Shi
    Lin, Pei
    Miranda, Roberto N.
    Jorgensen, Jeffrey L.
    McDonnell, Timothy J.
    Wang, Wei
    Kantarjian, Hagop M.
    Hu, Shimin
    BLOOD ADVANCES, 2017, 1 (26) : 2541 - 2552
  • [50] BLASTIC CRISIS WITH BASOFILA DIFFERENTIATION AS A DEBUT OF CHRONIC MYELOID LEUKEMIA
    Peralta-Benitez, R.
    Esteban-Figuerola, A.
    Pichardo-Condorhuaman, L.
    Aguinaga, L.
    Herrera-Perez, P.
    Hermosilla-Fernandez, M.
    Najera, M. J.
    Garcia Munoz, R.
    Feliu Sanchez, J.
    Campeny, A.
    Hernandez, M.
    Farfan, G.
    HAEMATOLOGICA, 2018, 103 : 354 - 355
12345